These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26739529)

  • 1. Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophy.
    Cao YY; Qu YJ; He SX; Li Y; Bai JL; Jin YW; Wang H; Song F
    J Zhejiang Univ Sci B; 2016 Jan; 17(1):76-82. PubMed ID: 26739529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition.
    Hauke J; Riessland M; Lunke S; Eyüpoglu IY; Blümcke I; El-Osta A; Wirth B; Hahnen E
    Hum Mol Genet; 2009 Jan; 18(2):304-17. PubMed ID: 18971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion analysis of SMN1 and NAIP genes in Southern Chinese children with spinal muscular atrophy.
    Liang YH; Chen XL; Yu ZS; Chen CY; Bi S; Mao LG; Zhou BL; Zhang XN
    J Zhejiang Univ Sci B; 2009 Jan; 10(1):29-34. PubMed ID: 19198020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study.
    Tiziano FD; Lomastro R; Di Pietro L; Barbara Pasanisi M; Fiori S; Angelozzi C; Abiusi E; Angelini C; Sorarù G; Gaiani A; Mongini T; Vercelli L; Vasco G; Vita G; Luca Vita G; Messina S; Politano L; Passamano L; Di Gregorio G; Montomoli C; Orsi C; Campanella A; Mantegazza R; Morandi L
    Eur J Hum Genet; 2013 Jun; 21(6):630-6. PubMed ID: 23073312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy type III: Molecular genetic characterization of Turkish patients.
    Bora-Tatar G; Yesbek-Kaymaz A; Bekircan-Kurt CE; Erdem-Özdamar S; Erdem-Yurter H
    Eur J Med Genet; 2015 Dec; 58(12):654-8. PubMed ID: 26548498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy diagnostics.
    Prior TW
    J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of survival motor neuron gene conversion in patients with spinal muscular atrophy].
    He SX; Ge XS; Qu YJ; Jin YW; Wang H; Bai JL; Song F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):606-11. PubMed ID: 22161088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
    Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
    Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission characteristics of SMN from 227 spinal muscular atrophy core families in China.
    Cao Y; Qu Y; Bai J; Cheng M; Jin Y; Wang H; Song F
    J Hum Genet; 2020 May; 65(5):469-473. PubMed ID: 32051521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients.
    Brkušanin M; Kosać A; Jovanović V; Pešović J; Brajušković G; Dimitrijević N; Todorović S; Romac S; Milić Rašić V; Savić-Pavićević D
    J Hum Genet; 2015 Nov; 60(11):723-8. PubMed ID: 26311540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.
    Harahap NI; Takeuchi A; Yusoff S; Tominaga K; Okinaga T; Kitai Y; Takarada T; Kubo Y; Saito K; Sa'adah N; Nurputra DK; Nishimura N; Saito T; Nishio H
    Brain Dev; 2015 Aug; 37(7):669-76. PubMed ID: 25459970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.
    He J; Zhang QJ; Lin QF; Chen YF; Lin XZ; Lin MT; Murong SX; Wang N; Chen WJ
    Gene; 2013 Apr; 518(2):325-9. PubMed ID: 23352792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal muscular atrophy patient detection and carrier screening using dried blood spots on filter paper.
    Harahap NI; Harahap IS; Kaszynski RH; Nurputra DK; Hartomo TB; Pham HT; Yamamoto T; Morikawa S; Nishimura N; Rusdi I; Widiastuti R; Nishio H
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):123-9. PubMed ID: 21942573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA).
    Rouzier C; Chaussenot A; Paquis-Flucklinger V
    Arch Pediatr; 2020 Dec; 27(7S):7S9-7S14. PubMed ID: 33357600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene.
    Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W
    J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T; Sato H; Lai PS; Nurputra DK; Harahap NI; Morikawa S; Nishimura N; Kurashige T; Ohshita T; Nakajima H; Yamada H; Nishida Y; Toda S; Takanashi J; Takeuchi A; Tohyama Y; Kubo Y; Saito K; Takeshima Y; Matsuo M; Nishio H
    Brain Dev; 2014 Nov; 36(10):914-20. PubMed ID: 24359787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy.
    Tran VK; Sasongko TH; Hong DD; Hoan NT; Dung VC; Lee MJ; Gunadi ; Takeshima Y; Matsuo M; Nishio H
    Pediatr Int; 2008 Jun; 50(3):346-51. PubMed ID: 18533950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.